// App-Quantinova.ai

2512 : Minimal Residual Disease Quantification in Acute Lymphoblastic Leukemia Using High-Throughput Sequencing of Multiple Immunoreceptor Genes Predicts Relapse and Survival After Allogeneic Hematopoietic Cell Transplantation.

Researchers

Presenter

  • Nikita Vashi

Principal Investigators

  • Malek Faham

  • James L. Zehnder

  • David B Miklos

  • Victoria Carlton

  • Ismael Buno

  • Jianbiao Zheng

  • Martin Moorhead

  • Mark Klinger

  • Tom Willis

  • Bing Zhang

  • Amna Waqar

Medical Centers

  • Department of Hematology, Gregorio Maranon General University Hospital, Madrid, Spain

Locations

  • Spain

Companies

  • Sequenta, Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Hematocrit

  • T cell receptor alpha locus

  • T cell receptor beta locus

  • T-cell receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved